カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のピラルビシン市場2022年：10mg剤形、20Mg剤形

◆英語タイトル：Global Pirarubicin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22MY8937 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年5月（※2025年版があります。お問い合わせください。） ◆ページ数：98 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医薬品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

ピラルビシン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のピラルビシンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ピラルビシン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・10mg剤形、20Mg剤形

用途別セグメントは次のように区分されます。
・乳がん、頭頸部がん、膀胱がん、尿管がん、腎盂がん、卵巣がん、子宮頸がん、悪性リンパ腫、急性白血病、その他

世界のピラルビシン市場の主要な市場プレーヤーは以下のとおりです。
・MicroBiopharm、Lilly、Nanjing Zhengda Tianqing Pharmaceutical、Harbin Yuheng Pharmaceutical、Shandong New Era Pharmaceutical、Zhejiang Haizheng Pharmaceutical、Shenzhen Wanle Pharmaceutical

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ピラルビシン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なピラルビシンメーカーの企業概要、2019年～2022年までのピラルビシンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なピラルビシンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ピラルビシンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのピラルビシンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのピラルビシン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびピラルビシンの産業チェーンを掲載しています。
・第13、14、15章では、ピラルビシンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：MicroBiopharm、Lilly、Nanjing Zhengda Tianqing Pharmaceutical、Harbin Yuheng Pharmaceutical、Shandong New Era Pharmaceutical、Zhejiang Haizheng Pharmaceutical、Shenzhen Wanle Pharmaceutical
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：10mg剤形、20Mg剤形
・用途別分析2017年-2028年：乳がん、頭頸部がん、膀胱がん、尿管がん、腎盂がん、卵巣がん、子宮頸がん、悪性リンパ腫、急性白血病、その他
・ピラルビシンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・ピラルビシンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・ピラルビシンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・ピラルビシンの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・ピラルビシンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Pirarubicin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Pirarubicin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Breast Cancer accounting for % of the Pirarubicin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 10 Mg Dosage Forms segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Pirarubicin include MicroBiopharm, Lilly, Nanjing Zhengda Tianqing Pharmaceutical, Harbin Yuheng Pharmaceutical, and Shandong New Era Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pirarubicin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
10 Mg Dosage Forms
20 Mg Dosage Forms
Market segment by Application can be divided into
Breast Cancer
Head And Neck Cancer
Bladder Cancer
Ureteral Carcinoma
Carcinoma Of The Renal Pelvis
Ovarian Cancer
Cervical Cancer
Malignant Lymphoma
Acute Leukemia
Other
The key market players for global Pirarubicin market are listed below:
MicroBiopharm
Lilly
Nanjing Zhengda Tianqing Pharmaceutical
Harbin Yuheng Pharmaceutical
Shandong New Era Pharmaceutical
Zhejiang Haizheng Pharmaceutical
Shenzhen Wanle Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pirarubicin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pirarubicin, with price, sales, revenue and global market share of Pirarubicin from 2019 to 2022.
Chapter 3, the Pirarubicin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pirarubicin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Pirarubicin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pirarubicin.
Chapter 13, 14, and 15, to describe Pirarubicin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Pirarubicin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pirarubicin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 10 Mg Dosage Forms
1.2.3 20 Mg Dosage Forms
1.3 Market Analysis by Application
1.3.1 Overview: Global Pirarubicin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Breast Cancer
1.3.3 Head And Neck Cancer
1.3.4 Bladder Cancer
1.3.5 Ureteral Carcinoma
1.3.6 Carcinoma Of The Renal Pelvis
1.3.7 Ovarian Cancer
1.3.8 Cervical Cancer
1.3.9 Malignant Lymphoma
1.3.10 Acute Leukemia
1.3.11 Other
1.4 Global Pirarubicin Market Size & Forecast
1.4.1 Global Pirarubicin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Pirarubicin Sales in Volume (2017-2028)
1.4.3 Global Pirarubicin Price (2017-2028)
1.5 Global Pirarubicin Production Capacity Analysis
1.5.1 Global Pirarubicin Total Production Capacity (2017-2028)
1.5.2 Global Pirarubicin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pirarubicin Market Drivers
1.6.2 Pirarubicin Market Restraints
1.6.3 Pirarubicin Trends Analysis
2 Manufacturers Profiles
2.1 MicroBiopharm
2.1.1 MicroBiopharm Details
2.1.2 MicroBiopharm Major Business
2.1.3 MicroBiopharm Pirarubicin Product and Services
2.1.4 MicroBiopharm Pirarubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Lilly
2.2.1 Lilly Details
2.2.2 Lilly Major Business
2.2.3 Lilly Pirarubicin Product and Services
2.2.4 Lilly Pirarubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Nanjing Zhengda Tianqing Pharmaceutical
2.3.1 Nanjing Zhengda Tianqing Pharmaceutical Details
2.3.2 Nanjing Zhengda Tianqing Pharmaceutical Major Business
2.3.3 Nanjing Zhengda Tianqing Pharmaceutical Pirarubicin Product and Services
2.3.4 Nanjing Zhengda Tianqing Pharmaceutical Pirarubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Harbin Yuheng Pharmaceutical
2.4.1 Harbin Yuheng Pharmaceutical Details
2.4.2 Harbin Yuheng Pharmaceutical Major Business
2.4.3 Harbin Yuheng Pharmaceutical Pirarubicin Product and Services
2.4.4 Harbin Yuheng Pharmaceutical Pirarubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Shandong New Era Pharmaceutical
2.5.1 Shandong New Era Pharmaceutical Details
2.5.2 Shandong New Era Pharmaceutical Major Business
2.5.3 Shandong New Era Pharmaceutical Pirarubicin Product and Services
2.5.4 Shandong New Era Pharmaceutical Pirarubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Zhejiang Haizheng Pharmaceutical
2.6.1 Zhejiang Haizheng Pharmaceutical Details
2.6.2 Zhejiang Haizheng Pharmaceutical Major Business
2.6.3 Zhejiang Haizheng Pharmaceutical Pirarubicin Product and Services
2.6.4 Zhejiang Haizheng Pharmaceutical Pirarubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Shenzhen Wanle Pharmaceutical
2.7.1 Shenzhen Wanle Pharmaceutical Details
2.7.2 Shenzhen Wanle Pharmaceutical Major Business
2.7.3 Shenzhen Wanle Pharmaceutical Pirarubicin Product and Services
2.7.4 Shenzhen Wanle Pharmaceutical Pirarubicin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Pirarubicin Breakdown Data by Manufacturer
3.1 Global Pirarubicin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Pirarubicin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Pirarubicin
3.4 Market Concentration Rate
3.4.1 Top 3 Pirarubicin Manufacturer Market Share in 2021
3.4.2 Top 6 Pirarubicin Manufacturer Market Share in 2021
3.5 Global Pirarubicin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Pirarubicin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pirarubicin Market Size by Region
4.1.1 Global Pirarubicin Sales in Volume by Region (2017-2028)
4.1.2 Global Pirarubicin Revenue by Region (2017-2028)
4.2 North America Pirarubicin Revenue (2017-2028)
4.3 Europe Pirarubicin Revenue (2017-2028)
4.4 Asia-Pacific Pirarubicin Revenue (2017-2028)
4.5 South America Pirarubicin Revenue (2017-2028)
4.6 Middle East and Africa Pirarubicin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Pirarubicin Sales in Volume by Type (2017-2028)
5.2 Global Pirarubicin Revenue by Type (2017-2028)
5.3 Global Pirarubicin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Pirarubicin Sales in Volume by Application (2017-2028)
6.2 Global Pirarubicin Revenue by Application (2017-2028)
6.3 Global Pirarubicin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Pirarubicin Sales by Type (2017-2028)
7.2 North America Pirarubicin Sales by Application (2017-2028)
7.3 North America Pirarubicin Market Size by Country
7.3.1 North America Pirarubicin Sales in Volume by Country (2017-2028)
7.3.2 North America Pirarubicin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Pirarubicin Sales by Type (2017-2028)
8.2 Europe Pirarubicin Sales by Application (2017-2028)
8.3 Europe Pirarubicin Market Size by Country
8.3.1 Europe Pirarubicin Sales in Volume by Country (2017-2028)
8.3.2 Europe Pirarubicin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Pirarubicin Sales by Type (2017-2028)
9.2 Asia-Pacific Pirarubicin Sales by Application (2017-2028)
9.3 Asia-Pacific Pirarubicin Market Size by Region
9.3.1 Asia-Pacific Pirarubicin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Pirarubicin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Pirarubicin Sales by Type (2017-2028)
10.2 South America Pirarubicin Sales by Application (2017-2028)
10.3 South America Pirarubicin Market Size by Country
10.3.1 South America Pirarubicin Sales in Volume by Country (2017-2028)
10.3.2 South America Pirarubicin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pirarubicin Sales by Type (2017-2028)
11.2 Middle East & Africa Pirarubicin Sales by Application (2017-2028)
11.3 Middle East & Africa Pirarubicin Market Size by Country
11.3.1 Middle East & Africa Pirarubicin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Pirarubicin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Pirarubicin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Pirarubicin
12.3 Pirarubicin Production Process
12.4 Pirarubicin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Pirarubicin Typical Distributors
13.3 Pirarubicin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Pirarubicin Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Pirarubicin Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. MicroBiopharm Basic Information, Manufacturing Base and Competitors
Table 4. MicroBiopharm Major Business
Table 5. MicroBiopharm Pirarubicin Product and Services
Table 6. MicroBiopharm Pirarubicin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Lilly Basic Information, Manufacturing Base and Competitors
Table 8. Lilly Major Business
Table 9. Lilly Pirarubicin Product and Services
Table 10. Lilly Pirarubicin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Nanjing Zhengda Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 12. Nanjing Zhengda Tianqing Pharmaceutical Major Business
Table 13. Nanjing Zhengda Tianqing Pharmaceutical Pirarubicin Product and Services
Table 14. Nanjing Zhengda Tianqing Pharmaceutical Pirarubicin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Harbin Yuheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. Harbin Yuheng Pharmaceutical Major Business
Table 17. Harbin Yuheng Pharmaceutical Pirarubicin Product and Services
Table 18. Harbin Yuheng Pharmaceutical Pirarubicin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Shandong New Era Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Shandong New Era Pharmaceutical Major Business
Table 21. Shandong New Era Pharmaceutical Pirarubicin Product and Services
Table 22. Shandong New Era Pharmaceutical Pirarubicin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Zhejiang Haizheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Zhejiang Haizheng Pharmaceutical Major Business
Table 25. Zhejiang Haizheng Pharmaceutical Pirarubicin Product and Services
Table 26. Zhejiang Haizheng Pharmaceutical Pirarubicin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Shenzhen Wanle Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 28. Shenzhen Wanle Pharmaceutical Major Business
Table 29. Shenzhen Wanle Pharmaceutical Pirarubicin Product and Services
Table 30. Shenzhen Wanle Pharmaceutical Pirarubicin Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Pirarubicin Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 32. Global Pirarubicin Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Pirarubicin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Pirarubicin Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Pirarubicin Production Site of Key Manufacturer
Table 36. Pirarubicin New Entrant and Capacity Expansion Plans
Table 37. Pirarubicin Mergers & Acquisitions in the Past Five Years
Table 38. Global Pirarubicin Sales by Region (2017-2022) & (K Units)
Table 39. Global Pirarubicin Sales by Region (2023-2028) & (K Units)
Table 40. Global Pirarubicin Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Pirarubicin Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Pirarubicin Sales by Type (2017-2022) & (K Units)
Table 43. Global Pirarubicin Sales by Type (2023-2028) & (K Units)
Table 44. Global Pirarubicin Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Pirarubicin Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Pirarubicin Price by Type (2017-2022) & (US$/Unit)
Table 47. Global Pirarubicin Price by Type (2023-2028) & (US$/Unit)
Table 48. Global Pirarubicin Sales by Application (2017-2022) & (K Units)
Table 49. Global Pirarubicin Sales by Application (2023-2028) & (K Units)
Table 50. Global Pirarubicin Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Pirarubicin Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Pirarubicin Price by Application (2017-2022) & (US$/Unit)
Table 53. Global Pirarubicin Price by Application (2023-2028) & (US$/Unit)
Table 54. North America Pirarubicin Sales by Country (2017-2022) & (K Units)
Table 55. North America Pirarubicin Sales by Country (2023-2028) & (K Units)
Table 56. North America Pirarubicin Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Pirarubicin Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Pirarubicin Sales by Type (2017-2022) & (K Units)
Table 59. North America Pirarubicin Sales by Type (2023-2028) & (K Units)
Table 60. North America Pirarubicin Sales by Application (2017-2022) & (K Units)
Table 61. North America Pirarubicin Sales by Application (2023-2028) & (K Units)
Table 62. Europe Pirarubicin Sales by Country (2017-2022) & (K Units)
Table 63. Europe Pirarubicin Sales by Country (2023-2028) & (K Units)
Table 64. Europe Pirarubicin Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Pirarubicin Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Pirarubicin Sales by Type (2017-2022) & (K Units)
Table 67. Europe Pirarubicin Sales by Type (2023-2028) & (K Units)
Table 68. Europe Pirarubicin Sales by Application (2017-2022) & (K Units)
Table 69. Europe Pirarubicin Sales by Application (2023-2028) & (K Units)
Table 70. Asia-Pacific Pirarubicin Sales by Region (2017-2022) & (K Units)
Table 71. Asia-Pacific Pirarubicin Sales by Region (2023-2028) & (K Units)
Table 72. Asia-Pacific Pirarubicin Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Pirarubicin Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Pirarubicin Sales by Type (2017-2022) & (K Units)
Table 75. Asia-Pacific Pirarubicin Sales by Type (2023-2028) & (K Units)
Table 76. Asia-Pacific Pirarubicin Sales by Application (2017-2022) & (K Units)
Table 77. Asia-Pacific Pirarubicin Sales by Application (2023-2028) & (K Units)
Table 78. South America Pirarubicin Sales by Country (2017-2022) & (K Units)
Table 79. South America Pirarubicin Sales by Country (2023-2028) & (K Units)
Table 80. South America Pirarubicin Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Pirarubicin Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Pirarubicin Sales by Type (2017-2022) & (K Units)
Table 83. South America Pirarubicin Sales by Type (2023-2028) & (K Units)
Table 84. South America Pirarubicin Sales by Application (2017-2022) & (K Units)
Table 85. South America Pirarubicin Sales by Application (2023-2028) & (K Units)
Table 86. Middle East & Africa Pirarubicin Sales by Region (2017-2022) & (K Units)
Table 87. Middle East & Africa Pirarubicin Sales by Region (2023-2028) & (K Units)
Table 88. Middle East & Africa Pirarubicin Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Pirarubicin Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Pirarubicin Sales by Type (2017-2022) & (K Units)
Table 91. Middle East & Africa Pirarubicin Sales by Type (2023-2028) & (K Units)
Table 92. Middle East & Africa Pirarubicin Sales by Application (2017-2022) & (K Units)
Table 93. Middle East & Africa Pirarubicin Sales by Application (2023-2028) & (K Units)
Table 94. Pirarubicin Raw Material
Table 95. Key Manufacturers of Pirarubicin Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Pirarubicin Typical Distributors
Table 99. Pirarubicin Typical Customers
List of Figures
Figure 1. Pirarubicin Picture
Figure 2. Global Pirarubicin Revenue Market Share by Type in 2021
Figure 3. 10 Mg Dosage Forms
Figure 4. 20 Mg Dosage Forms
Figure 5. Global Pirarubicin Revenue Market Share by Application in 2021
Figure 6. Breast Cancer
Figure 7. Head And Neck Cancer
Figure 8. Bladder Cancer
Figure 9. Ureteral Carcinoma
Figure 10. Carcinoma Of The Renal Pelvis
Figure 11. Ovarian Cancer
Figure 12. Cervical Cancer
Figure 13. Malignant Lymphoma
Figure 14. Acute Leukemia
Figure 15. Global Pirarubicin Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 16. Global Pirarubicin Revenue and Forecast (2017-2028) & (USD Million)
Figure 17. Global Pirarubicin Sales (2017-2028) & (K Units)
Figure 18. Global Pirarubicin Price (2017-2028) & (US$/Unit)
Figure 19. Global Pirarubicin Production Capacity (2017-2028) & (K Units)
Figure 20. Global Pirarubicin Production Capacity by Geographic Region: 2022 VS 2028
Figure 21. Pirarubicin Market Drivers
Figure 22. Pirarubicin Market Restraints
Figure 23. Pirarubicin Market Trends
Figure 24. Global Pirarubicin Sales Market Share by Manufacturer in 2021
Figure 25. Global Pirarubicin Revenue Market Share by Manufacturer in 2021
Figure 26. Pirarubicin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 27. Top 3 Pirarubicin Manufacturer (Revenue) Market Share in 2021
Figure 28. Top 6 Pirarubicin Manufacturer (Revenue) Market Share in 2021
Figure 29. Global Pirarubicin Sales Market Share by Region (2017-2028)
Figure 30. Global Pirarubicin Revenue Market Share by Region (2017-2028)
Figure 31. North America Pirarubicin Revenue (2017-2028) & (USD Million)
Figure 32. Europe Pirarubicin Revenue (2017-2028) & (USD Million)
Figure 33. Asia-Pacific Pirarubicin Revenue (2017-2028) & (USD Million)
Figure 34. South America Pirarubicin Revenue (2017-2028) & (USD Million)
Figure 35. Middle East & Africa Pirarubicin Revenue (2017-2028) & (USD Million)
Figure 36. Global Pirarubicin Sales Market Share by Type (2017-2028)
Figure 37. Global Pirarubicin Revenue Market Share by Type (2017-2028)
Figure 38. Global Pirarubicin Price by Type (2017-2028) & (US$/Unit)
Figure 39. Global Pirarubicin Sales Market Share by Application (2017-2028)
Figure 40. Global Pirarubicin Revenue Market Share by Application (2017-2028)
Figure 41. Global Pirarubicin Price by Application (2017-2028) & (US$/Unit)
Figure 42. North America Pirarubicin Sales Market Share by Type (2017-2028)
Figure 43. North America Pirarubicin Sales Market Share by Application (2017-2028)
Figure 44. North America Pirarubicin Sales Market Share by Country (2017-2028)
Figure 45. North America Pirarubicin Revenue Market Share by Country (2017-2028)
Figure 46. United States Pirarubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Canada Pirarubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Mexico Pirarubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Europe Pirarubicin Sales Market Share by Type (2017-2028)
Figure 50. Europe Pirarubicin Sales Market Share by Application (2017-2028)
Figure 51. Europe Pirarubicin Sales Market Share by Country (2017-2028)
Figure 52. Europe Pirarubicin Revenue Market Share by Country (2017-2028)
Figure 53. Germany Pirarubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Pirarubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Pirarubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Pirarubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Pirarubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Pirarubicin Sales Market Share by Region (2017-2028)
Figure 59. Asia-Pacific Pirarubicin Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Pirarubicin Sales Market Share by Region (2017-2028)
Figure 61. Asia-Pacific Pirarubicin Revenue Market Share by Region (2017-2028)
Figure 62. China Pirarubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Pirarubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Korea Pirarubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Pirarubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Pirarubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Pirarubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Pirarubicin Sales Market Share by Type (2017-2028)
Figure 69. South America Pirarubicin Sales Market Share by Application (2017-2028)
Figure 70. South America Pirarubicin Sales Market Share by Country (2017-2028)
Figure 71. South America Pirarubicin Revenue Market Share by Country (2017-2028)
Figure 72. Brazil Pirarubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Argentina Pirarubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Middle East & Africa Pirarubicin Sales Market Share by Type (2017-2028)
Figure 75. Middle East & Africa Pirarubicin Sales Market Share by Application (2017-2028)
Figure 76. Middle East & Africa Pirarubicin Sales Market Share by Region (2017-2028)
Figure 77. Middle East & Africa Pirarubicin Revenue Market Share by Region (2017-2028)
Figure 78. Turkey Pirarubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Egypt Pirarubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Saudi Arabia Pirarubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. South Africa Pirarubicin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 82. Manufacturing Cost Structure Analysis of Pirarubicin in 2021
Figure 83. Manufacturing Process Analysis of Pirarubicin
Figure 84. Pirarubicin Industrial Chain
Figure 85. Sales Channel: Direct Channel vs Indirect Channel
Figure 86. Methodology
Figure 87. Research Process and Data Source

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のピラルビシン市場2022年：10mg剤形、20Mg剤形(Global Pirarubicin Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のピラルビシン市場2022年：10mg剤形、20Mg剤形

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp